Ensitrelvir marks a breakthrough in anti-COVID treatment, paving the way for future defenses against betacoronaviruses.

To most people on the planet, the Covid-19 pandemic is over. But for many scientists who have been tracking the largest global infectious disease event in the era of molecular biology, there is still ...

A new study led by researchers at the University of Malaga proposes a new antiviral strategy against SARS-CoV-2—the virus ...

SARS-CoV-2 variants continue to evolve (even if they are no longer making headlines.) In August, researchers detected a new SARS-CoV-2 “variant of concern” in patients, first in Israel and Denmark.

A recent study published in the journal Frontiers in Molecular Biosciences applied computational approaches to study the binding mechanisms of the severe acute respiratory syndrome coronavirus 2 (SARS ...

Announcing a new article publication for Zoonoses journal. Zoonotic transmission of severe acute respiratory coronavirus 2 (SARS-CoV-2) has been found to result in infections in more than 30 mammalian ...

It’s that time of year: a thick, oppressive heat blankets everything, people huddle inside air-conditioned homes, offices, shops and cafes for respite—and COVID is surging again. Levels of SARS-CoV-2, ...

RSV, and PIV are associated with a higher risk for acute respiratory failure, highlighting the need for increased monitoring and preventive interventions in hospitalized patients. Patients ...

Multisystem inflammatory syndrome in children (MIS-C), a delayed hyperinflammatory response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is an important cause of illness ...

On Monday, April 10, President Joe Biden signed a bill that immediately terminated the COVID-19 national emergency, first enacted in 2020 as the SARS-CoV-2 virus gripped the country. So does this mean ...